Abstract
Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic?
Highlights
In this retrospective cohort study at a tertiary care center in France, patients who underwent liver biopsy and received MRI as part of their clinical workup within 3 months were
Data on 142 patients were available and 37% of these had advanced fibrosis defined as the histological disease stages F3 and F4
The concept to use liver surface nodularity (LSN) to detect advanced liver fibrosis on CT scan has previously successfully shown for hepatic fibrosis of different indications [8], chronic viral hepatitis c [9], and portal hypertension [10]
Summary
In this retrospective cohort study at a tertiary care center in France, patients who underwent liver biopsy and received MRI as part of their clinical workup within 3 months were. 1 Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg-University, Langenbeckstrasse 1, 55131 Mainz, Germany 2 Metabolic Liver Research Program, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
